Mesenchymal Stromal Cells and Extracellular Vesicles: A Novel Therapeutic Paradigm for Mitochondrial Dysfunctions
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041981 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Eman Salem Algariri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Extracellular Vesicles, Mitochondria, Mitochondrial Diseases. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Universiti Kebangsaan Malaysia.
Abstract (Originalsprache)
Mitochondrial dysfunction is a central pathological feature of a wide range of inherited and acquired disorders and is characterized by impaired oxidative phosphorylation, disrupted cellular energy metabolism, and excessive oxidative stress. Although advances in molecular diagnostics have improved disease recognition, effective disease-modifying therapies remain limited, and clinical outcomes are often suboptimal, highlighting the need for novel therapeutic strategies. Mesenchymal stromal cells (MSCs) and their extracellular vesicles (MSC-EVs) have emerged as promising candidates for targeting mitochondrial dysfunction due to their regenerative, immunomodulatory, and metabolic regulatory properties. In this review, we provide a comprehensive overview of recent in vitro and in vivo studies investigating the capacity of MSCs and MSC-EVs to restore mitochondrial function by enhancing mitochondrial respiration, improving cellular bioenergetics, and reducing oxidative stress across diverse disease models. We further discuss the underlying mechanisms involved, including mitochondrial transfer, delivery of functional mitochondrial components, and modulation of the cellular microenvironment. Finally, we highlight the key advantages, translational potential, and remaining challenges associated with MSC- and MSC-EV-based therapies for mitochondrial dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
- Institute for Medical Research (IMR), National Institutes of Health (NIH), Ministry of Health Malaysia, Shah Alam 40170, Selangor, Malaysia.
- Department of Biochemistry, Faculty of Medicine, Universiti Kebangsaan Malaysia, Cheras, Kuala Lumpur 56000, Malaysia.
- Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Minden 11800, Penang, Malaysia.
- Malaysian Institute of Pharmaceuticals and Nutraceuticals, National Institutes of Biotechnology Malaysia, Gelugor 11700, Penang, Malaysia.
- Department of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
ORCID-Profile: Fazlina Nordin, Norwahidah Abdul Karim, Gee Jun Tye
Förderung
- Faculty of Medicine, Universiti Kebangsaan Malaysia
Zitieren
APA
Algariri, E. S., Nordin, F., Ng, M. H., Mohd Idris, I., Abdul Karim, N., Tye, G. J., & Wan Kamarul Zaman, W. S. (2026). Mesenchymal Stromal Cells and Extracellular Vesicles: A Novel Therapeutic Paradigm for Mitochondrial Dysfunctions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041981
Vancouver
Algariri ES, Nordin F, Ng MH, Mohd Idris I, Abdul Karim N, Tye GJ, et al. Mesenchymal Stromal Cells and Extracellular Vesicles: A Novel Therapeutic Paradigm for Mitochondrial Dysfunctions. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041981
BibTeX
@article{Algariri2026,
author = {Algariri, Eman Salem and Nordin, Fazlina and Ng, Min Hwei and Mohd Idris, Izyan and Abdul Karim, Norwahidah and Tye, Gee Jun and Wan Kamarul Zaman, Wan Safwani},
title = {Mesenchymal Stromal Cells and Extracellular Vesicles: A Novel Therapeutic Paradigm for Mitochondrial Dysfunctions},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041981}
}
EUVIMED